Adaptimmune Therapeutics Plc Overview

Adaptimmune Therapeutics Plc Gross Profit

Gross Profit analysis for ADAP.

Quarterly Gross Profit

$11.18M

↓ 91.1% YoY

As of Jun 30, 2025

Annual Gross Profit (TTM)

$61.70M

↓ 52.64% YoY

Trailing 12 months ending Jun 30, 2025

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin